These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Stromal CD4 (+) T Cell Subsets Mediate Antitumor Cytotoxic Immune Responses in Human Colorectal Carcinoma. Fukushima G; Sato E; Udo R; Tago T; Kasahara K; Mazaki J; Iwasaki K; Enomoto M; Ishizaki T; Nagakawa Y Anticancer Res; 2024 Sep; 44(9):3899-3906. PubMed ID: 39197911 [TBL] [Abstract][Full Text] [Related]
23. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study. Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584 [TBL] [Abstract][Full Text] [Related]
25. Characterisation of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancer. Diederichsen AC; Zeuthen J; Christensen PB; Kristensen T Eur J Cancer; 1999 May; 35(5):721-6. PubMed ID: 10505031 [TBL] [Abstract][Full Text] [Related]
26. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study. Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725 [TBL] [Abstract][Full Text] [Related]
27. Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer. Teng F; Meng X; Kong L; Mu D; Zhu H; Liu S; Zhang J; Yu J Transl Res; 2015 Dec; 166(6):721-732.e1. PubMed ID: 26209749 [TBL] [Abstract][Full Text] [Related]
28. Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer. Chaput N; Svrcek M; Aupérin A; Locher C; Drusch F; Malka D; Taïeb J; Goéré D; Ducreux M; Boige V Br J Cancer; 2013 Aug; 109(4):1013-22. PubMed ID: 23868006 [TBL] [Abstract][Full Text] [Related]
29. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis. Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744 [TBL] [Abstract][Full Text] [Related]
30. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer. Wang K; Shen T; Siegal GP; Wei S Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275 [TBL] [Abstract][Full Text] [Related]
31. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer. Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453 [TBL] [Abstract][Full Text] [Related]
32. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283 [TBL] [Abstract][Full Text] [Related]
33. Increased number of forkhead box P3+ tumor-infiltrating lymphocytes correlates with high preoperative albumin level and better survival in patients with stage II or III colorectal cancer. Wang DL; Liu YY; Gu YL; Qin Y; Ji HF; Wu LH; Qi N; Su D; Huang SH; Zhang YQ Tumour Biol; 2015 Jul; 36(7):5407-14. PubMed ID: 25697896 [TBL] [Abstract][Full Text] [Related]
34. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Webb JR; Milne K; Watson P; Deleeuw RJ; Nelson BH Clin Cancer Res; 2014 Jan; 20(2):434-44. PubMed ID: 24190978 [TBL] [Abstract][Full Text] [Related]
35. Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer. Lee HJ; Park IA; Song IH; Shin SJ; Kim JY; Yu JH; Gong G J Clin Pathol; 2016 May; 69(5):422-30. PubMed ID: 26475777 [TBL] [Abstract][Full Text] [Related]
36. Phenotype analysis of tumour-infiltrating lymphocytes and lymphocytes in peripheral blood in patients with renal carcinoma. Kopecký O; Lukesová S; Vroblová V; Vokurková D; Morávek P; Safránek H; Hlávková D; Soucek P Acta Medica (Hradec Kralove); 2007; 50(3):207-12. PubMed ID: 18254275 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis. Jiang D; Gao Z; Cai Z; Wang M; He J BMC Cancer; 2015 Oct; 15():727. PubMed ID: 26475790 [TBL] [Abstract][Full Text] [Related]
38. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429 [TBL] [Abstract][Full Text] [Related]
39. Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy. Halama N; Michel S; Kloor M; Zoernig I; Benner A; Spille A; Pommerencke T; von Knebel DM; Folprecht G; Luber B; Feyen N; Martens UM; Beckhove P; Gnjatic S; Schirmacher P; Herpel E; Weitz J; Grabe N; Jaeger D Cancer Res; 2011 Sep; 71(17):5670-7. PubMed ID: 21846824 [TBL] [Abstract][Full Text] [Related]
40. The prognostic role of tumour-infiltrating lymphocytes in oral squamous cell carcinoma: A meta-analysis. Huang Z; Xie N; Liu H; Wan Y; Zhu Y; Zhang M; Tao Y; Zhou H; Liu X; Hou J; Wang C J Oral Pathol Med; 2019 Oct; 48(9):788-798. PubMed ID: 31323145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]